Enanta Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KRENSAVAGE ASSET MANAGEMENT, LLC | 02/18/2025 | 2.12 M | $12.18 M | 41.34% | 10.01% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.11 M | $12.12 M | 0.00% | 9.96% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.04 M | $11.73 M | 7.33% | 9.60% |
| VANGUARD GROUP INC | 02/11/2025 | 1.98 M | $11.41 M | 0.12% | 9.38% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.04 M | $5.97 M | 100.00% | 4.91% |
| MARSHALL WACE, LLP | 02/13/2025 | 930,087 | $5.35 M | 9.31% | 4.38% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 896,987 | $5.16 M | 22.66% | 4.24% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 849,424 | $4.88 M | 0.00% | 4.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 498,000 | $2.86 M | -5.12% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 477,231 | $2.74 M | -0.03% | 2.26% |
| STATE STREET CORP | 02/14/2025 | 460,984 | $2.65 M | 2.45% | 2.17% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 421,594 | $2.42 M | -15.91% | 1.99% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 331,900 | $1.91 M | 100.00% | 1.56% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 297,106 | $1.71 M | 52.79% | 1.40% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 192,856 | $1.11 M | 34.11% | 0.91% |
| CALIGAN PARTNERS LP | 02/14/2025 | 184,826 | $1.06 M | -42.68% | 0.87% |
| SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 177,004 | $1.02 M | 0.00% | 0.84% |
| JPMORGAN CHASE & CO | 02/12/2025 | 163,113 | $937,901 | -33.05% | 0.77% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 161,679 | $929,654 | 33.60% | 0.76% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 159,729 | $918,442 | -6.38% | 0.76% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 156,300 | $898,725 | -32.92% | 0.74% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 154,827 | $890,255 | -4.66% | 0.73% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 135,954 | $781,736 | 97.28% | 0.64% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 126,655 | $728,266 | 0.00% | 0.60% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 123,861 | $712,201 | -22.65% | 0.59% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 85,649 | $492,482 | -42.68% | 0.40% |
| FMR LLC | 02/13/2025 | 77,584 | $446,108 | 57.37% | 0.37% |
| SEI INVESTMENTS CO | 02/11/2025 | 72,789 | $418,540 | -0.19% | 0.34% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 71,104 | $408,848 | 100.81% | 0.34% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 70,427 | $404,955 | -78.55% | 0.33% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 64,283 | $369,627 | -66.39% | 0.30% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 60,364 | $347,093 | -61.57% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 57,120 | $328,441 | -1.73% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 55,607 | $319,741 | 0.00% | 0.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 51,298 | $294,964 | 47.62% | 0.24% |
| INVESCO LTD. | 02/13/2025 | 46,614 | $268,031 | 7.34% | 0.22% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 46,200 | $265,650 | -3.75% | 0.22% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 46,099 | $265,070 | 21.77% | 0.22% |
| BARCLAYS PLC | 02/13/2025 | 45,508 | $262,000 | 65.86% | 0.22% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/10/2025 | 44,102 | $254,000 | 100.00% | 0.21% |
| NORGES BANK | 02/12/2025 | 40,700 | $234,025 | 100.00% | 0.19% |
| RHUMBLINE ADVISERS | 01/30/2025 | 37,091 | $213,263 | 2.56% | 0.18% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 36,962 | $212,532 | 10.46% | 0.17% |
| SHERBROOKE PARK ADVISERS LLC | 02/14/2025 | 33,451 | $192,343 | 100.00% | 0.16% |
| PDT PARTNERS, LLC | 02/14/2025 | 33,449 | $192,332 | 0.32% | 0.16% |
| PORTLAND GLOBAL ADVISORS LLC | 02/12/2025 | 33,185 | $190,814 | 0.00% | 0.16% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 31,748 | $182,551 | 100.00% | 0.15% |
| UBS GROUP AG | 02/14/2025 | 31,152 | $179,124 | 6.19% | 0.15% |
| JANE STREET GROUP, LLC | 02/14/2025 | 31,072 | $178,664 | 34.07% | 0.15% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 30,726 | $177,000 | 100.00% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enanta Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 177 institutional investors and hedge funds held shares of Enanta Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Krensavage Asset Management, LLC: 2.12 M
FARALLON CAPITAL MANAGEMENT LLC: 2.11 M
BlackRock Funding, Inc. /DE: 2.04 M
VANGUARD GROUP INC: 1.98 M
RA CAPITAL MANAGEMENT, L.P.: 1.04 M
MARSHALL WACE, LLP: 930,087
90.82% of Enanta Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 27.85 M shares in the last 24 months. This purchase volume represents approximately $155.12 M in transactions.